Sierk Poetting
At a glance: Sierk Poetting is COO at BioNTech SE (BNTX). Their latest SEC Form 4, filed Apr 23, 2026, reported a sale of $5.5M. On file: 0 purchase lines ($0) and 1 sale line ($5.5M).
Disclosed holdings: about $32.2M of BNTX stock: 399,387 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Apr 23, 2026), valued at the Nov 20, 2026 close of $80.59. This counts only BNTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
COO at BioNTech SE (BNTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 23SEC | BNTXBioNTech SE | Sell Plan | 50,000399,387 held (−11%) | $110.56 | $5.5M | -27.1% |
- Sell
COO Sierk Poetting sold $5.5M of BNTX at $110.56 — pre-scheduled 10b5-1 plan sale.
Follow Sierk Poetting
Get one email when Sierk Poetting files a new purchase or sale. Free.
At most one email a day about Sierk Poetting, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.